Arnold S Han, MD

Our research investigates the function of T cells as they pertain to human diseases, including cancer and autoimmunity.

We have recently developed technology than enables determination of T-cell antigen receptor (TCR) sequence and high-dimensional (> 30 parameters) functional phenotype with high accuracy and efficiency from single T cells. Pairing TCR sequence information with high-dimensional phenotypic analysis is particularly powerful in the analysis of T cells, which are exceptionally diverse. In addition to the theoretical TCR repertoire diversity of 1015, T cells can assume diverse pro-inflammatory and regulatory functions. Our approach enables the extensive study of T cell function and also the ability to recapitulate TCRs for functional studies and therapeutic application.

We now understand that T cells are fundamentally capable of recognizing and rejecting tumors as foreign tissue, and tumors grow because they have devised mechanisms of escaping T cell immunity. Recently, therapies specifically designed to incite anti-tumor T cell activity have shown enormous promise in cancer treatment. Our research investigates the function of T cells in human cancer and in mouse models with ultimate aim of identifying novel avenues of therapy. We are addressing the following questions:

1) Of the diverse types of T cells present in tumors, which T cells have potential in controlling cancer and which T cells might actually be promoting cancer growth?

2) How does the TCR repertoire of tumor infiltrating T cells compare with peripheral blood and normal tissue?

3) How do tumor-infiltrating T cells evolve over time?

4) What are the antigens driving T cells in cancer?

5) How does immunotherapy affect the landscape and function of T cells, and what are T cell determinants of responsiveness to immunotherapy?

6) Can we apply our technology to design effective strategies for adoptive T cell immunotherapy?

Like cancer, autoimmune diseases are also diseases of T cell tolerance. Our laboratory studies autoimmunity through the study of celiac disease, a highly prevalent autoimmune disease that shares similar genetic and immunologic features with other autoimmune diseases. Aside from its clinical impact, celiac disease is unique among autoimmune diseases in that the triggering antigen, dietary gluten, is known and its exposure can be controlled through diet. Thus, celiac disease provides a unique opportunity to study and understand human autoimmunity. We are investigating T cell responses within celiac disease through the study of blood and tissue from human volunteers. We have previously shown that CD8+ T cells in celiac disease, which mediate tissue damage, are likely responding to gluten ingestion in an antigen-specific manner, even though CD8+ T cells are not believed to directly recognize gluten peptides. Our research on celiac disease is focused on understanding how a CD4+ T cell response directed against an external antigen (dietary gluten) can enable self-tissue damage by CD8+ T cells.

I am trained as a clinical gastroenterologist and a basic scientist with expertise in immunology. I am applying my very unique training as both a basic scientist trained in immunology and a clinician trained in Internal Medicine and Gastroenterology to pursue clinically important scientific questions in tumor immunity and autoimmunity. My team investigates the function of T cells as they pertain to human diseases. We have developed and are actively developing technologies that enable the study of T cell function and specificity at a single-cell level. We are applying this analysis to the study of T cells in cancer and autoimmune diseases. Our approach enables the extensive study of T cell function and also the ability to recapitulate TCRs for functional studies and therapeutic application.